Format

Send to

Choose Destination
Annu Rev Microbiol. 2015;69:71-92. doi: 10.1146/annurev-micro-091014-104330.

Candida albicans Biofilms and Human Disease.

Author information

1
Department of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, California 95343; email: cnobile@ucmerced.edu.
2
Department of Microbiology and Immunology, University of California, San Francisco, California 94143; email: ajohnson@cgl.ucsf.edu.

Abstract

In humans, microbial cells (including bacteria, archaea, and fungi) greatly outnumber host cells. Candida albicans is the most prevalent fungal species of the human microbiota; this species asymptomatically colonizes many areas of the body, particularly the gastrointestinal and genitourinary tracts of healthy individuals. Alterations in host immunity, stress, resident microbiota, and other factors can lead to C. albicans overgrowth, causing a wide range of infections, from superficial mucosal to hematogenously disseminated candidiasis. To date, most studies of C. albicans have been carried out in suspension cultures; however, the medical impact of C. albicans (like that of many other microorganisms) depends on its ability to thrive as a biofilm, a closely packed community of cells. Biofilms are notorious for forming on implanted medical devices, including catheters, pacemakers, dentures, and prosthetic joints, which provide a surface and sanctuary for biofilm growth. C. albicans biofilms are intrinsically resistant to conventional antifungal therapeutics, the host immune system, and other environmental perturbations, making biofilm-based infections a significant clinical challenge. Here, we review our current knowledge of biofilms formed by C. albicans and closely related fungal species.

KEYWORDS:

fungi; infection; microbial community; microbiota; pathogen; transcriptional regulation

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center